Artificial intelligence is reshaping how embryologists evaluate embryos during IVF. Systems like ERICA, iDAScore, and Life Whisperer now analyze time-lapse images to predict which embryos have the highest implantation potential — sometimes catching patterns human graders miss entirely.
But the technology is still young, and marketing often outpaces evidence. Here is what the clinical data actually shows, what AI embryo selection costs, and the questions worth asking before your transfer.
How AI Embryo Grading Works
Traditional embryo grading relies on a morphologist examining cell symmetry, fragmentation, and development timing under a microscope. It is subjective — two embryologists can grade the same embryo differently up to 30% of the time.
AI systems use deep learning algorithms trained on thousands of time-lapse embryo images paired with known outcomes (implantation, live birth, or failure). The algorithm identifies micro-patterns in cell division timing, symmetry, and expansion that correlate with viability.
What the Evidence Shows
A 2024 randomized controlled trial published in Fertility and Sterility involving over 1,000 patients found that AI-assisted selection improved clinical pregnancy rates by approximately 10% compared to conventional morphology grading alone. However, the improvement in live birth rates was smaller and not statistically significant in all subgroups.
The strongest evidence supports AI as a complement to — not replacement for — experienced embryologists. The technology excels at reducing inter-observer variability and identifying subtle timing abnormalities that human eyes miss during static evaluation.
| AI System | Studies | Key Finding |
|---|---|---|
| iDAScore | 12+ peer-reviewed | Reduced embryologist disagreement by ~50% |
| ERICA (Fairtility) | 8+ publications | Comparable to senior embryologist grading |
| Life Whisperer | 6+ publications | Strong blastocyst viability prediction |
| CHLOE (TMRW) | Emerging data | Focus on euploid prediction without biopsy |
AI vs PGT-A: Different Tools, Different Questions
AI embryo selection and PGT-A testing answer fundamentally different questions. PGT-A tells you whether an embryo has the correct number of chromosomes. AI predicts implantation potential based on developmental behavior. They are complementary, not interchangeable.
Some clinics now use AI as a first-pass filter before deciding which embryos to biopsy for PGT-A, potentially reducing the number of biopsies needed and lowering costs.
Cost and Availability
AI embryo grading typically adds $500 to $1,500 per cycle, depending on the clinic and system used. Some clinics absorb the cost when they already use time-lapse incubators. Others charge it as an add-on alongside PGT-A.
Availability is growing rapidly. As of mid-2026, an estimated 30-40% of high-volume US fertility clinics offer some form of AI-assisted embryo assessment, though many do not market it explicitly.
Questions to Ask Your Clinic
- Which AI system do you use, and what peer-reviewed data supports it?
- Does AI replace or supplement your embryologist's assessment?
- Is the cost bundled or added on separately?
- How does AI grading interact with your PGT-A recommendations?
- What is your clinic-specific data on outcomes with vs. without AI selection?
The Bottom Line
AI embryo selection is a genuine advancement, not a gimmick — but it is also not a guarantee. The technology works best as one data point in a multi-factor transfer decision that includes embryo genetics, patient age, uterine receptivity, and clinical judgment. Ask your RE how AI fits into their specific transfer protocol rather than assuming every clinic uses it the same way.
Continue Your Research
Track Your Cycle
OPK comparisons, BBT charts, and timing guides for every cycle type.
FertileStart →Optimize Your Body
Evidence-based supplements, nutrition plans, and lifestyle changes for fertility.
LifeFertile →The Full Picture
Your central hub for fertility news, research updates, and getting started.
HowToHaveABaby →